» Articles » PMID: 22022363

Low Concentrations of Methamphetamine Can Protect Dopaminergic Cells Against a Larger Oxidative Stress Injury: Mechanistic Study

Overview
Journal PLoS One
Date 2011 Oct 25
PMID 22022363
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Mild stress can protect against a larger insult, a phenomenon termed preconditioning or tolerance. To determine if a low intensity stressor could also protect cells against intense oxidative stress in a model of dopamine deficiency associated with Parkinson disease, we used methamphetamine to provide a mild, preconditioning stress, 6-hydroxydopamine (6-OHDA) as a source of potentially toxic oxidative stress, and MN9D cells as a model of dopamine neurons. We observed that prior exposure to subtoxic concentrations of methamphetamine protected these cells against 6-OHDA toxicity, whereas higher concentrations of methamphetamine exacerbated it. The protection by methamphetamine was accompanied by decreased uptake of both [(3)H] dopamine and 6-OHDA into the cells, which may have accounted for some of the apparent protection. However, a number of other effects of methamphetamine exposure suggest that the drug also affected basic cellular survival mechanisms. First, although methamphetamine preconditioning decreased basal pERK1/2 and pAkt levels, it enhanced the 6-OHDA-induced increase in these phosphokinases. Second, the apparent increase in pERK1/2 activity was accompanied by increased pMEK1/2 levels and decreased activity of protein phosphatase 2. Third, methamphetamine upregulated the pro-survival protein Bcl-2. Our results suggest that exposure to low concentrations of methamphetamine cause a number of changes in dopamine cells, some of which result in a decrease in their vulnerability to subsequent oxidative stress. These observations may provide insights into the development of new therapies for prevention or treatment of PD.

Citing Articles

Protective Effect of Low Dose of Methamphetamine on The Amount of Extracellular Glutamine in Primary Fetal Human Astrocytes Induced by Amyloid Beta.

Soltanian B, Shasaltaneh M, Riazi G, Masoudian N Cell J. 2022; 24(3):105-111.

PMID: 35451579 PMC: 9035228. DOI: 10.22074/cellj.2022.7917.


5-Methoxyindole-2-Carboylic Acid (MICA) Fails to Retard Development and Progression of Type II Diabetes in ZSF1 Diabetic Rats.

Li C, Ma W, Yan L React Oxyg Species (Apex). 2020; 9(27):144-147.

PMID: 32551363 PMC: 7301685.


Identification of cytotoxic markers in methamphetamine treated rat C6 astroglia-like cells.

Badisa R, Wiley C, Randell K, Darling-Reed S, Latinwo L, Agharahimi M Sci Rep. 2019; 9(1):9412.

PMID: 31253835 PMC: 6599005. DOI: 10.1038/s41598-019-45845-1.


Astrocytic clasmatodendrosis in the cerebral cortex of methamphetamine abusers.

Zhang Z, Gong Q, Feng X, Zhang D, Quan L Forensic Sci Res. 2018; 2(3):139-144.

PMID: 30483632 PMC: 6197099. DOI: 10.1080/20961790.2017.1280890.


Conditioning Against the Pathology of Parkinson's disease.

Leak R Cond Med. 2018; 1(3):143-162.

PMID: 30370426 PMC: 6200356.


References
1.
Hoshida S, Yamashita N, Otsu K, Hori M . The importance of manganese superoxide dismutase in delayed preconditioning: involvement of reactive oxygen species and cytokines. Cardiovasc Res. 2002; 55(3):495-505. DOI: 10.1016/s0008-6363(02)00337-1. View

2.
Ravati A, Ahlemeyer B, Becker A, Klumpp S, Krieglstein J . Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB. J Neurochem. 2001; 78(4):909-19. DOI: 10.1046/j.1471-4159.2001.00463.x. View

3.
Tai K, Truong D . Activation of adenosine triphosphate-sensitive potassium channels confers protection against rotenone-induced cell death: therapeutic implications for Parkinson's disease. J Neurosci Res. 2002; 69(4):559-66. DOI: 10.1002/jnr.10309. View

4.
Kita T, Wagner G, Nakashima T . Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption. J Pharmacol Sci. 2003; 92(3):178-95. DOI: 10.1254/jphs.92.178. View

5.
Mattson M, Duan W, Wan R, Guo Z . Prophylactic activation of neuroprotective stress response pathways by dietary and behavioral manipulations. NeuroRx. 2005; 1(1):111-6. PMC: 534916. DOI: 10.1602/neurorx.1.1.111. View